The current status of mycophenolate mofetil in pediatric renal transplantation
- 1 February 1999
- journal article
- Published by Wiley in Pediatric Transplantation
- Vol. 3 (1) , 5-9
- https://doi.org/10.1034/j.1399-3046.1999.00021.x
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- What is the role for mycophenolate mofetil in pediatric renal transplantation?Pediatric Transplantation, 1999
- Mycophenolate mofetil – is it worth the cost? The in‐favor opinionPediatric Transplantation, 1999
- A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1Transplantation, 1998
- MYCOPHENOLATE MOFETIL-BASED, CYCLOSPORINE-FREE INDUCTION AND MAINTENANCE IMMUNOSUPPRESSIONTransplantation, 1998
- IMMUNOSUPPRESSIVE THERAPY IN HIGH-RISK TRANSPLANT PATIENTSTransplantation, 1997
- STEROID WITHDRAWAL IN MYCOPHENOLATE MOFETIL-TREATED RENAL ALLOGRAFT RECIPIENTSTransplantation, 1997
- MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF REFRACTORY, ACUTE, CELLULAR RENAL TRANSPLANT REJECTION1Transplantation, 1996
- Inhibition of chronic vascular rejection in primate cardiac xenografts using mycophenolate mofetilThe Annals of Thoracic Surgery, 1994
- Human Type I and II IMP Dehydrogenases as Drug TargetsAnnals of the New York Academy of Sciences, 1993
- IMMUNOLOGICAL OBSERVATIONS ON PATENTS WITH LESCH-NYHAN SYNDROME, AND ON THE ROLE OF DE-NOVO PURINE SYNTHESIS IN LYMPHOCYTE TRANSFORMATIONThe Lancet, 1975